March 2003

|
Volume 11 Issue 3

Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com
First Annual Ohio River Valley Cardiovascular Symposium is a Huge Success
What if you read comments like: Excellent breakout sessions; Symposium and entertainment were excellent; SICP should be commended; Very well-planned and thought out; I’ve attended these type of meetings in Cincinnati, Texas, Tennessee, and…
2003 American College of Cardiology Exhibitor Preview
Abbott Vascular Visit Abbott Vascular at ACC Booth # 2403 For more information, call (800) 222-6883 or go to www.perclose.com. Amersham Health Visit Amersham Health at ACC Booth # 3048 For more information, call (609) 514-6000 or go to www.ame…
A Meditative View
NULL
What Do You Think?
Patient Follow Up Our lab is going to start following patients after discharge to home. The plan is to call patients at home and ask them various questions about their post-hospital recovery period. We’d like to know what other labs do in regards to…
Clinical Events Calendar
March 27 - 29 14th Annual ACCA Cardiovascular Administrators’ Management Conference American College of Cardiovascular Administrators is a specialty group of the American Academy of Medical Administrators Managing the Winds of Change: Evolution, Eth…
Cath Lab Digest Email Discussion Group
The following Email Discussion Group was sponsored by the Society for Invasive Cardiovascular Professionals (SICP). Does your hospital plan on stocking drug-eluting stents? If yes, will you have strict criteria for usage? Patient Selection Criter…
In Brief: Original Research Abstracts from the Journal of Invasive Cardiology
Safety and Efficacy of Cutting Balloon Angioplasty:The Mayo Clinic Experience James L. Orford, MBChB, MPH, Panayotis Fasseas, MD, Ali E. Denktas, MD, LaVon Hammes, Kirk N. Garratt, MD, Peter B. Berger, MD, David R. Holmes, MD, Gregory W. Barsness, MD…
Clinical and Industry News I
Boston Scientific Announces European Launch of Its TAXUS Paclitaxel-Eluting Stent System Boston Scientific Corporation announced that it has initiated the launch of its TAXUS® paclitaxel-eluting stent system in Europe and other international markets…
Clinical and Industry News II
HIV Drugs Don’t Increase Heart Risk Fears that the drugs used to treat people infected with HIV cause an increased risk of heart attack and stroke appear to be unfounded, at least over the short term, researchers report. While it is possible there…
Stent implantation injures the arterial wall, which results in the initiation of injury and thrombosis on the arterial wall. Growth factors and cytokines that are released stimulate smooth muscle cells that migrate and results in intimal hyperplasia, resu
CME/CEU OFFERING: Sirolimus-Eluting Stents: A Leap Forward in the Prevention of Restenosis After Percutaneous Coronary Interve
A new era in cardiovascular care may soon be upon us, with the FDA aproval of drug-eluting stents fast approaching. This new type of therapy has many in the medical industry buzzing over potential clinical outcomes and overall reduction in repeat rev…